2013 | A Pilot Study for Preoperative Concurrent Chemoradiotherapy with S-1 and Cisplatin for Locally Advanced Gastric Cancer | HEPATO-GASTROENTEROLOGY |
2014 | A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| ONCOTARGET |
2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
2013 | Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | RADIOTHERAPY AND ONCOLOGY |
2017 | Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
| CANCER RESEARCH AND TREATMENT |
2021 | Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer
| RADIATION ONCOLOGY |
2003 | Eleven-Year Experience of Low Grade Lymphoma in Korea (Based on REAL Classification)
| YONSEI MEDICAL JOURNAL |
2015 | Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
| ONCOTARGET |
2019 | High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2017 | Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer | CLINICAL & TRANSLATIONAL ONCOLOGY |
2014 | Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation. | DIGESTION |
2017 | Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer | BRITISH JOURNAL OF SURGERY |
2002 | Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial
| SEIZURE-EUROPEAN JOURNAL OF EPILEPSY |
2004 | Low grade gastric mucosa associated lymphoid tissue lymphoma; treatment strategies based on 10 year follow-up
| WORLD JOURNAL OF GASTROENTEROLOGY |
2019 | Management of Clinical T1N0M0 Esophageal Cancer
| GUT AND LIVER |
2015 | Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer
| WORLD JOURNAL OF GASTROENTEROLOGY |
2012 | Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | RADIOTHERAPY AND ONCOLOGY |
2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
| ONCOTARGET |
2019 | Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer | RADIOTHERAPY AND ONCOLOGY |
2016 | PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
| ONCOTARGET |
2014 | Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer | DIGESTIVE AND LIVER DISEASE |
2016 | Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration | JOURNAL OF SURGICAL ONCOLOGY |
1998 | Sensory and motor dysfunction assessed by anorectal manometry in uterine cervical carcinoma patients with radiation-induced late rectal complication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2010 | Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma.
| WORLD JOURNAL OF GASTROENTEROLOGY |